Biotech Startups
10,028 companies tagged Biotech, with their investors and founders.
0 investors
OncBioMune is a clinical-stage biopharmaceutical company developing novel cancer immunotherapy products using proprietary vaccine technology designed to stimulate immune response against cancer cells. The company focuses on treatments for prostate cancer and other oncology indications, with its lead product in Phase 2 development.
0 investors
Oncobiomix develops AI-powered microbiome diagnostics and therapeutics, using gut microbiome analysis as a "biosensor" for cancer detection and gut health. The company offers microbiome testing (RebiomiX) in which samples undergo microbial DNA extraction and AI-based analysis to generate health reports.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Onconetix is a commercial-stage biotechnology company that researches, develops, and commercializes proprietary therapeutics, diagnostics, and services in oncology. It serves clinicians and patients, with a product line that includes the Proclarix diagnostic.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Oncotelic is a biopharmaceutical company developing oncology therapeutics, including immuno-oncology and nanomedicine approaches, and applying AI technology to drug development. It focuses on cancer treatments and other therapeutic areas.
0 investors
0 investors
ONCOtracker is an incubator-stage biotech company developing approaches for monitoring and treating patients with multiple myeloma, other B-cell malignancies, and related disorders. It is part of a family of oncology-focused companies associated with the Berenson Cancer Center in the United States.
0 investors
0 investors
0 investors
0 investors
OneOme is a precision medicine company that provides pharmacogenomics testing and analytics to healthcare providers, helping them optimize medication selection based on patients' genetic profiles. Co-founded by Mayo Clinic, the company serves healthcare teams and institutions globally seeking to improve patient outcomes and reduce costs through personalized medication decisions.
0 investors
OnKologic (Enable Life Sciences) develops Enable-NK cell culture media and a 10x concentrated supplement for expanding Natural Killer (NK) cells, used by NK cell research groups and in immuno-oncology cell therapy development. The products aim to improve NK cell performance metrics such as cytotoxicity, transduction efficiency, and cryopreservation for cancer research applications.
0 investors